dc.date.accessioned2021-06-08T15:46:14Z
dc.date.available2021-06-08T15:46:14Z
dc.date.created2021-06-08T15:46:14Z
dc.date.issued2021
dc.identifierhttps://hdl.handle.net/20.500.12866/9493
dc.identifierhttps://doi.org/10.1093/femspd/ftab028
dc.description.abstractCutaneous leishmaniasis (CL) is an infectious and neglected disease caused by parasites of the genus Leishmania, which produces a wide spectrum of cutaneous manifestations. CL research has shown that the innate immune activity of cells such as neutrophils, natural killers, macrophages, dendritic cells, and the complement system are capable of controlling this infection. However, Leishmania can also modulate the immune activity of these cells to promote its own survival and proliferation at the intracellular level. This review discusses the role of the innate immune response in the control and spread of this infection
dc.languageeng
dc.publisherOxford University Press
dc.relationPathogens and Disease
dc.relation2049-632X
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectLeishmania
dc.subjectinfection
dc.subjecthost-pathogen interaction
dc.subjectimmune system
dc.subjectinnate immunity
dc.titleInnate immune response: ally or enemy in cutaneous leishmaniasis?
dc.typeinfo:eu-repo/semantics/review


Este ítem pertenece a la siguiente institución